Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Participants With Advanced Solid Tumor Malignancies”

755 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 755 results

Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Study completedNCT01919398
What this trial is testing

LY2940680 in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 19
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Early research (Phase 1)Study completedNCT02004106
What this trial is testing

Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 110
Early research (Phase 1)Study completedNCT05501821
What this trial is testing

Study of KBA1412 in Participants With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Tumor Malignancy
Kling Biotherapeutics B.V. 16
Early research (Phase 1)Looking for participantsNCT06349408
What this trial is testing

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Early research (Phase 1)Study completedNCT01362374
What this trial is testing

Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 122
Early research (Phase 1)Not Yet RecruitingNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Early research (Phase 1)Study completedNCT00962091
What this trial is testing

Study of MLN8237 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Millennium Pharmaceuticals, Inc. 53
Early research (Phase 1)Looking for participantsNCT06804824
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 220
Early research (Phase 1)Study completedNCT02650713
What this trial is testing

The Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 228
Testing effectiveness (Phase 2)Study completedNCT04622774
What this trial is testing

First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
ImmunoGen, Inc. 56
Early research (Phase 1)Ended earlyNCT05904496
What this trial is testing

BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 44
Early research (Phase 1)Study completedNCT03873883
What this trial is testing

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Who this might be right for
Solid Tumor, Adult
iTeos Therapeutics 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Testing effectiveness (Phase 2)Ended earlyNCT05450562
What this trial is testing

Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors

Who this might be right for
Neoplasm
Sanofi 33
Early research (Phase 1)Active Not RecruitingNCT03843359
What this trial is testing

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 97
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Early research (Phase 1)Looking for participantsNCT06555744
What this trial is testing

ZW191 in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Zymeworks BC Inc. 145
Load More Results